These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10883040)

  • 1. [(Mis)information on drugs: the double standard practiced by pharmaceutical companies].
    Barros JA
    Cad Saude Publica; 2000; 16(2):421-7. PubMed ID: 10883040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One more case of the double standard: discrepancies between drug information provided to Brazilian and American physicians.
    de Barros JA
    Pharmacoepidemiol Drug Saf; 2000 Jul; 9(4):281-7. PubMed ID: 19025829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advertising of drugs: risk or benefits?].
    Barros JA
    Gac Sanit; 1996; 10(53):81-90. PubMed ID: 8755160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?
    Woloshin S; Schwartz LM; Tremmel J; Welch HG
    Lancet; 2001 Oct; 358(9288):1141-6. PubMed ID: 11597668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical advertisements in leading medical journals: experts' assessments.
    Wilkes MS; Doblin BH; Shapiro MF
    Ann Intern Med; 1992 Jun; 116(11):912-9. PubMed ID: 1580449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.
    Uhl K; Kennedy DL; Kweder SL
    Drug Saf; 2002; 25(12):885-92. PubMed ID: 12241129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of advertising on neurological drugs received during the medical consultation].
    Sanchez de Paz MP; Latella AN; Falero A; Lerman D; Bignone IMI; Rojas G
    Medicina (B Aires); 2021; 81(4):559-564. PubMed ID: 34453797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An innovative approach to educating medical students about pharmaceutical promotion.
    Wilkes MS; Hoffman JR
    Acad Med; 2001 Dec; 76(12):1271-7. PubMed ID: 11739058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians.
    Spiller LD; Wymer WW
    Health Mark Q; 2001; 19(1):91-106. PubMed ID: 11727295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic messages in prescription drug advertisements in medical journals.
    Neumann PJ; Zivin Bambauer K; Ramakrishnan V; Stewart KA; Bell CM
    Med Care; 2002 Sep; 40(9):840-5. PubMed ID: 12218774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug marketing in French-speaking African countries.
    Chirac P; Pikon A; Poinsignon Y; Vitry A
    Soc Sci Med; 1993 Jun; 36(12):1541-3. PubMed ID: 8327917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
    Gaedeke RM; Tootelian DH; Sanders EE
    Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influences of drug companies' advertising programs on physicians.
    Güldal D; Semin S
    Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bioethical analysis of drugs advertisement and publicity].
    Fagundes MJ; Soares MG; Diniz NM; Pires JR; Garrafa V
    Cien Saude Colet; 2007; 12(1):221-9. PubMed ID: 17680073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doctors and detailers: therapeutic education or pharmaceutical promotion?
    Lexchin J
    Int J Health Serv; 1989; 19(4):663-79. PubMed ID: 2583883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
    Castresana L; Mejia R; Aznar M
    Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.